Next Frontier for Access to NCD Care: Launch Event
PATH, Novo Nordisk, Pfizer, the Ministries of Health of Kenya, Senegal, and Uganda, the NCD Alliance, RTI International, the World Heart Federation, NCD Child, International Pediatric Association, the International Federation of Pharmaceutical Manufacturers, and Teva, guided by the founding multisectoral Technical Advisory Committee, cordially invite you to the launch of the Coalition for Access to NCD Medicines & Products on Monday, September 18, 2017, from 3:00 to 5:00 pm at the Westin New York Grand Central Hotel (Madison Ballroom) in New York City, followed by a 5:00 to 6:00 pm reception co-hosted by PATH and the NCD Alliance.
The program will convene leaders and experts from all sectors and across global health and development, and will feature an interactive panel on the “Next Frontier for Access to NCD Care,” which will link cutting-edge developments and thinking in the field with the global priorities of the 72nd United Nations General Assembly. Confirmed speakers include Sir George Alleyne, Director Emeritus, Pan American Health Organization; Steve Davis, CEO of PATH; Rebecca Martin, Director, Center for Global Health, US Centers for Disease Control and Prevention; Jean Claude Mbanya, Professor of Medicine and Endocrinology, University of Yaoundé I; Prashant Yadav, Visiting Scholar, Harvard Medical School; Khawar Mann, Partner, The Abraaj Group; Sania Nishtar, Founder and President, Heartfile; Peter Singer, CEO of Grand Challenges Canada; and more.
Noncommunicable diseases (NCDs) such as diabetes and cardiovascular disease are the leading cause of death and disability worldwide. Fortunately, effective treatment is possible with tools that already exist. Nevertheless, NCDs cost low- and middle-income countries trillions of dollars, partially due to inadequate access to essential medicines and health products (EMPs). We need concentrated, engaged, country-focused, multisectoral partnership to identify and break down associated barriers so that we can achieve the Sustainable Development Goals and realize the promise of universal health coverage (UHC).
The Coalition for Access to NCD Medicines & Products is a federation of representatives from government, civil society, academia, nongovernmental organizations, and the private sector dedicated to overcoming key operational barriers to accessing affordable EMPs for NCDs in order to save lives, foster prosperity, and advance the global movement toward UHC.